Skip to content
drillr.ai
Sign up

06872.HK

TENNOR THERAP-B

HKSE · Healthcare · Biotechnology · CN

HKD 122.70
+0.66%
Ask drillr

  • Aug 26, 2026, 09:28 UTC

    Dano Pharmaceutical-B (06872.HK) reported interim results for the six months ended June 2026, with net loss narrowing to RMB 64.245 million from RMB 78.17 million in the same period last year, and no dividend declared.

    Source: